NCT00006370View on ClinicalTrials.gov

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Breast CancerLung Cancer
Interventions
RADIATION

yttrium Y 90-edotreotide

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY